Gains:
- Ability to pre-screen drug evaluation in pregnancy/lactation, children, elderly and kidney/liver failure patients with artificial intelligence
- Ability to mark high-risk outcomes by confirming special group dose adjustments with SmPC, guide and reliable source
- Ability to understand that these groups are at high risk and that the final decision should be made in collaboration with the physician and pharmacist.
Medication safety is defined for the “average adult”; But most patients who come to the pharmacy do not fit this average. A pregnant woman, a baby weighing several kilograms, an elderly person taking eight medications, a patient whose kidneys work at half capacity; They all respond differently to medication and each carries high risk. In these groups, a small dose error or an overlooked contraindication (drawback) can cause serious harm. Artificial intelligence is a powerful pre-screening and reminder tool when assessing these groups; Highlights a forgotten dosage setting, a contraindication or a safety question. However, due to the high risk of these groups, each result should be carefully verified and the decision should be made in collaboration with the physician and pharmacist. In this unit, you will learn to use artificial intelligence safely in special patient groups.
Why private groups are different
The unique physiology of each group modifies drug behavior:
- Pregnancy and lactation: The drug may cross the placenta and affect the baby, or may pass into breast milk and affect the breastfeeding baby. Some medications are dangerous during certain periods of pregnancy.
- Pediatrics (child): Dosage is usually calculated based on weight (mg/kg); organ systems are not yet mature and some medications cannot be used under certain ages.
- Geriatrics (elderly): Kidney/liver function is decreased, multiple drug use (polypharmacy) is common, and risks such as falls and confusion increase.
- Organ failure: Drug excretion is impaired in kidney or liver failure; dose reduction or drug change may be required.
Artificial intelligence can remind these groups of “points to pay attention to”; But the exact dose and decision are determined by current sources and expert evaluation.
Caution: Private group information is updated rapidly and AI may return information that is outdated, public, or from a different source. Statements like "probably safe" are never tolerated in these groups; Each decision is clarified with the current SmPC/safety source and physician.
Renal function and dosage adjustment
In renal failure, dosage adjustment is based on a value such as creatinine clearance (a measure of the kidney's filtration rate, mL/min). Many drugs require dose reduction or avoidance of use below a certain clearance threshold. AI asks “may this medication require kidney adjustment?” It can remind you of the question and help calculate clearance; but the exact threshold and rate are taken from the SmPC, and the calculation is independently verified.
Liver failure is a more difficult area than kidney failure because there is no simple measure that expresses liver function with a single number (such as clearance). Many drugs are metabolized (broken down and become inactive or excretable) in the liver; When this process is disrupted in liver failure, the drug may accumulate or behave differently than expected. Because of this uncertainty, relying on general information provided by AI in liver failure is particularly risky; The decision is made by the relevant section of the SmPC and often by expert (hepatology/clinical) evaluation. Artificial intelligence is just a reminder here that raises the question "Is this drug excreted through the liver? Is caution required?"
three mini cases
Case 1 — Pain relief during pregnancy. A pregnant patient asked about a pain reliever for a headache. In the pre-screening, artificial intelligence warned that "some painkillers may be harmful in the last period of pregnancy, they should be confirmed from the SPC and pregnancy safety source" and listed alternative evaluation questions. Instead of directly recommending a product, the pharmacist evaluated the pregnancy period and the SPC, and referred the patient to a physician when in doubt. AI reminded a red flag; The decision was made by the pharmacist and the physician.
Case 2 — Pediatric dose limit. He was asked whether a medication prescribed to a 2-year-old child was contraindicated under a certain age. Artificial intelligence said, "This drug group is not recommended for some products under certain ages, confirm in the pediatric use section of the SmPC." The pharmacist confirmed the age limit in the SPC, confirmed eligibility, and independently calculated the mg/kg dose. Artificial intelligence made the right question asked; KÜB clarified the border.
Case 3 — Polypharmacy in the elderly. For a 78-year-old patient using 9 medications, the pharmacist asked the artificial intelligence to pre-screen for drugs that may be risky in the elderly and possible duplication/interaction. The AI flagged several caution points and combinations that could increase the risk of falling. The pharmacist confirmed each item with the current source and guide and recommended a medication review to the physician. Artificial intelligence scanned the large list and prioritized; The decision was made in cooperation between the physician and the pharmacist.
Private group assessment step by step
- Define the group and context. Pregnancy period/child's age-weight/number of medications in the elderly/organ function (anonymous).
- Request pre-screening. Receive group-specific attention points and questions from AI.
- Confirm with current source. Verify each item from the SmPC, safety reference and manual.
- Make calculations independently. Resolve calculations such as mg/kg, clearance.
- Mark high risk and take it to the physician. In case of uncertainty or concern, decide with your doctor.
- Record the decision and justification.
Weak prompt / Strong prompt
Weak: "Can a pregnant patient take this medicine?"
Strong: "List the safety points that should be evaluated and the questions to be asked for [drug] in a pregnant patient (period: [trimester]) as a pre-screening. DECIDE MAKING; state that each item should be confirmed from the current SmPC and pregnancy safety source, and write in which cases it should be referred to the physician. Do not make a 'safe/unsafe' judgment."
In the strong prompt, the group context, boundary and validation condition are clear; Judgment is left to the pharmacist-physician.
Four copyable templates
Task: Pregnancy/lactation pre-screening (JUDGMENT).Medication: [...]. Period: [trimester/lactation]. Output: safety points to be evaluated + questions to be asked + referral situations to the physician. Add "SmPC/security source confirmation" to each item.
Task: Pediatric suitability checklist.Medication: [...]. Child: age [...], weight [...].Control: is there an age limit? mg/kg dose range? Is the form appropriate? maximum dose?Add "confirmation from SPC pediatric department" to each item. Show mg/kg calculation, pharmacist will verify.
Task: Geriatric drug review pre-screening.Medication list: [...]. Patient: age [...], kidney/liver [...]. Output: drugs that may be risky in the elderly, duplication, risk of fall/confusion, interaction. Prioritize; Each item will be confirmed with the source. The decision is made by the physician-pharmacist.
Task: Renal dosing pre-screening. Drug: [...]. Estimated clearance: [...] mL/min.Output: does this drug require adjustment for clearance (yes/no/unclear), at what threshold. Get the exact rate from SPC; Show clearance calculation, pharmacist will verify.
Custom group risk and verification table
Group
Main risk
Mandatory verification
Pregnancy/lactation
Fetus/infant exposure
SmPC + pregnancy safety resource + physician
pediatrics
Dosage/age limit error
SPC pediatric department + mg/kg independent calculation
geriatrics
Polypharmacy, falls, interaction
Guide + drug review + physician
kidney failure
Accumulation, toxicity
SPC dose adjustment + clearance calculation
liver failure
metabolic disorder
SmPC + expert evaluation
Common mistakes
- Based on the statement "probably safe". In these groups, uncertainty is carried to the physician.
- Applying general knowledge to specific group. Adult dosage cannot be directly adapted to child/elderly.
- Accepting the age/clearance limit without SmPC. The exact threshold is always confirmed in the SmPC.
- Looking at polypharmacy one by one. In the elderly, medications should be reviewed as a whole.
- Bypassing physician collaboration. In the high-risk group, the decision is not made alone.
In summary
Special patient groups (pregnancy, children, elderly, organ failure) are at high risk and respond differently to the drug. AI is a powerful pre-screening tool that highlights cautions, contraindications, and dosing questions in these groups. But since the information is updated rapidly and the risk is high, each output should be confirmed with the current SmPC/safety source, calculations should be made independently and the decision should be made in collaboration with the physician and pharmacist. The judgment "probably safe" can never be relied upon.
Application task
Set up an anonymous scenario for four special groups (pregnant, 3-year-old child, 80-year-old polypharmacy patient, clearance 25 mL/min patient). For each, ask the AI to evaluate it with the appropriate pre-screening template. Confirm each dose/limit/contraindication in the printout with the SmPC or guideline; Independently check the mg/kg dose for the child and the setting threshold for the kidney patient. Write down which items you will carry to the doctor and the reasons.
checklist
- [ ] I defined the group and context anonymously.
- [ ] I received group-specific pre-screening.
- [ ] I have confirmed each dose/limit/contraindication with the current SmPC/reference.
- [ ] I made mg/kg and clearance calculations independently.
- [ ] I didn't rely on "probably safe" statements.
- [ ] I took high-risk substances to the doctor.
- [ ] I recorded the decision and its justification.